Axim Biotechnologies Inc narrowed III. Quarter net loss per share of $-0.01 compare to net loss per share of $-0.02 recorded in the same quarter a year ago a decrease compare to $-0.01 realized in previous quarter.
III. Quarter
Earnings Per Share
Revenues
$ -0.01
$
0 Mill
$+0.01
Unch.-83.83 %
Axim Biotechnologies Inc 's Revenue
fell by
-83.83 % in III. Quarter (Sep 30 2022) year on year,
to $0 million and
advanced by
sequentially.
Axim Biotechnologies Inc is Expected to report next financial results on April 18, 2023.
Axim Biotechnologies Inc 's
in III. Quarter recorded net loss of $-2.035 million, an improvement compare to net loss of $-3.292 million in III. Quarter a year ago.
Inventories declined by -0.19 % to $0.02 million from III. Quarter a year ago, sequentially inventories fell by 0 %.
AXIM's Cash flow
In III. Quarter company's net cash flow was $0 million, capital expenditures fell by
